PTEN and melanoma: Mouse melanoma model carrying the frequent mutation of the BRAF oncogene (V600E) and PTEN deletion shows the repression of a protective immune response in the TME which was counteracted by an autophagy inducer, metformin, which determines tumor growth inhibition.